WHC is still in active development. Read this to understand our approach.
depiction of NPNUFJAVOOONJE-UHFFFAOYSA-N.svg
isomerdesign

β-Caryophyllene

Check on isomerdesign

drugmap

Beta-caryophyllene

Check on drugmap

Data

InChI: InChI=1S/C15H24/c1-11-6-5-7-12(2)13-10-15(3,4)14(13)9-8-11/h6,13-14H,2,5,7-10H2,1,3-4H3

Synonyms: Bicyclo[7.2.0]undec-4-ene, 4,11,11-trimethyl-8-methylene-, [1R-(1R*,4E,9S*)]-, DSSTox_RID_77517, Caryophyllene, (E), Caryophyllene, (-)- -caryophyllene, trans-Caryophyllene, (-)-(E)-Caryophyllene, UNII-K4H93P747O component NPNUFJAVOOONJE-GFUGXAQUSA-N, trans-(1R,9S)-4,11,11-trimethyl-8-methylenebicyclo[7.2.0]undec-4-ene, (1R,4E,9S)-4,11,11-trimethyl-8-methylene-bicyclo[7.2.0]undec-4-ene, (1S,9R)-6,10,10-trimethyl-2-methylenebicyclo[7.2.0]undec-5-ene, V0915, Caryophyllene B, beta-Caryophyllene, (-), NCGC00255159-01, L-Caryophyllene, g-Caryophyllene, W-109317, Bicyclo[7.2.0]undec-4-ene, 4,11,11-trimethyl-8-methylene-, (E)-(1R,9S)-(-)-, CHEMBL445740, beta-trans-Caryophyllene, (-)-trans-Caryophyllene, analytical standard, (-)-trans-Caryophyllene, >=98.5% (sum of enantiomers, GC), beta-trans-caryophyllene, HY-N1415, trans-(1R,9S)-8-Methylene-4,11,11-trimethylbicyclo[7.2.0]undec-4-ene, beta-(e)-caryophyllene, Tincturoid, Bicyclo[7.2.0]undec-4-ene, 8-methylene-4,11,11-trimethyl-, (E)-(1R,9S)-(-)-, (1R,4E,9S)-4,11,11-trimethyl-8-methylenebicyclo[7.2.0]undec-4-ene, (-)-I(2)-caryophyllene, ZINC8234282, (-)-beta-caryophyllene, Tox21_301497, UNII-BHW853AU9H, (E)-beta-caryophylene, 87-44-5, NSC 11906, (E)-Caryophyllene, CS-0016839, E-beta-caryophyllene, 8-Methylene-4,11,11-(trimethyl)bicyclo[7.2.0]undec-4-ene, s6058, beta-Caryophyllen, trans-.beta.-Caryophyllene, beta-caryophillene, DSSTox_CID_4739, E-.beta.-caryophyllene, C09629, CAS-87-44-5,β-Caryophyllene, Bicyclo[7.2.0]undec-4-ene, 4,11,11-trimethyl-8-methylene-, [1R- (1R*,4E,9S*)]-, (1R,9S,E)-4,11,11-trimethyl-8-methylenebicyclo[7.2.0]undec-4-ene, 8-Methylene-4,11,11-(trimethyl)bicyclo(7.2.0)undec-4-ene, (1R,4E,9S)-, BHW853AU9H,BETA-CARYOPHYLLENE, (-)-Caryophyllene, DTXSID8024739, Q421614, (E)-beta-caryophyllene, MFCD00075925, Beta-Caryophylene, AKOS024283988, beta-cariofillene, NCGC00142620-01, (-)-trans-Caryophyllene, beta-Caryophyllene, DSSTox_GSID_24739, LMPR0103120001, Bicyclo(7.2.0)undec-4-ene, 8-methylene-4,11,11-trimethyl-, (E)-(1R,9S)-(-)-, BDBM50529607, (1R,4E,9S)-4,11,11-trimethyl-8-methylidenebicyclo[7.2.0]undec-4-ene, beta-Caryophyllene, >=80%, FCC, FG, trans-beta-caryophyllene, CHEBI:10357, b-caryophyllene, beta-(E)-Caryophyllene, NSC11906, ST072181


Estimated data

Solubility: -5.799 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 59.4% (prediction based on www.mdpi.com)

Similarities

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.